Administration of Astragalus polysaccharide in bleomycin-induced systemic sclerosis mice reduced the collagen production in skin tissue, also downregulating the TGF-β1, MCP-1, Smad2, and Smad3 mRNA expressions. The gene discussed is SMAD2; the disease is systemic sclerosis.